Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?

Clinical trial NCT02740894 · COMPLETED

Trial details

NCT number: NCT02740894
Sponsor: Taipei Veterans General Hospital, Taiwan
Status: COMPLETED
Study type: OBSERVATIONAL

Is Targeted Therapy Increasing Survival Inoperable Nonsmall Cell Lung Cancer With Spinal Metastasis ?

Start date: 2016-02-01
Primary completion: 2016-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.